Stelvio Oncology Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Out of Business

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Out of Business

Stelvio Oncology General Information

Description

Operator of a biotechnology company designed to help oncologists focus on developing a pipeline of novel epigenetic-modifying drugs. The company's treatments will induce the differentiation of tumor-propagating cells into non-tumorigenic cells in a potent new strategy to fight GBM, enabling oncologists to access more viable cure alternatives for patients.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 3210 Merryfield Row
  • San Diego, CA 92121
  • United States
+1 (604)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 3210 Merryfield Row
  • San Diego, CA 92121
  • United States
+1 (604)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Stelvio Oncology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 24-May-2026 Completed Out of Business
4. Secondary Transaction - Private 01-Jun-2023 Completed Generating Revenue
3. Early Stage VC 18-May-2018 Completed Generating Revenue
2. Accelerator/Incubator 27-Mar-2018 $250K Completed Generating Revenue
1. Accelerator/Incubator 02-May-2017 $250K $250K Completed Startup
To view Stelvio Oncology’s complete valuation and funding history, request access »

Stelvio Oncology Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology company designed to help oncologists focus on developing a pipeline of novel epigenetic-modi
Drug Discovery
San Diego, CA
2 As of 2018

Austin, TX
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Stelvio Oncology Competitors (5)

One of Stelvio Oncology’s 5 competitors is Curtana Pharmaceuticals, a Venture Capital-Backed company based in Austin, TX.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Curtana Pharmaceuticals Venture Capital-Backed Austin, TX
Aurora Biosciences Formerly VC-backed San Diego, CA
DNAtrix Venture Capital-Backed Houston, TX
Astex Pharmaceuticals Corporate Backed or Acquired Cambridge, United Kingdom
Medicenna Therapeutics Formerly VC-backed Toronto, Canada
You’re viewing 5 of 5 competitors. Get the full list »

Stelvio Oncology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Stelvio Oncology FAQs

  • When was Stelvio Oncology founded?

    Stelvio Oncology was founded in 2017.

  • Where is Stelvio Oncology headquartered?

    Stelvio Oncology is headquartered in San Diego, CA.

  • What is the size of Stelvio Oncology?

    Stelvio Oncology has 2 total employees.

  • What industry is Stelvio Oncology in?

    Stelvio Oncology’s primary industry is Drug Discovery.

  • Is Stelvio Oncology a private or public company?

    Stelvio Oncology is a Private company.

  • What is Stelvio Oncology’s current revenue?

    The current revenue for Stelvio Oncology is .

  • How much funding has Stelvio Oncology raised over time?

    Stelvio Oncology has raised $250K.

  • Who are Stelvio Oncology’s competitors?

    Curtana Pharmaceuticals, Aurora Biosciences, DNAtrix, Astex Pharmaceuticals, and Medicenna Therapeutics are competitors of Stelvio Oncology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process